[ORGANIZATION]
Vyvgart Hytrulo
Featured in 1 tracked story · first seen
Also covered in
-
Argenx shares surge following successful Phase III myositis study
[BUSINESS] · 4 sources ·
[ORGANIZATION]
Featured in 1 tracked story · first seen
[BUSINESS] · 4 sources ·